Mohammad Ali Sahraian (M A Sahraian)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 21

Top Topics

Multiple Sclerosis

Hodgkin Lymphoma

Spectrum Disorder

Top Venues

Archives of Iranian medicine

Basic and clinical neuroscience

The International journal of neuroscience

Journal of neurovirology

This page only lists publications with an associated author ORCID identifier.

Publications

Abdorreza Naser Moghadasi, Mohammad Ali Sahraian, Sharareh Eskandarieh
Progressive Multiple Sclerosis Patients Requiring Special Attention as a Group at Risk for Coronavirus Infection. Basic and clinical neuroscience 15 (2) (2024)
Abdorreza Naser Moghadasi, Mohammad Ali Sahraian, Sharareh Eskandarieh
Progressive Multiple Sclerosis Patients Requiring Special Attention as a Group at Risk for Coronavirus Infection. Basic and clinical neuroscience 15 (2) (2024)
Abdorreza Naser Moghadasi, Fereshteh Ashtari, Seyed Mohammad Baghbanian, Vahid Shaygannejad, Nassim Anjidani, Fereshteh Ghadiri, Behnaz Sedighi, Morteza Saeidi, Hamed Amirifard, Hormoz Ayromlou, Nahid Beladi Moghadam, Mohammad Bagher Ranjbar, Masoume Nazeri, Zahra Niknam, Fardin Faraji, Afsaneh Afsorde, Mohammad Ali Sahraian
Safety and Effectiveness of Cinnomer ® on Disease Characteristics, Depression, and Quality of Life of Patients with Multiple Sclerosis: A Phase IV, Post-marketing, Prospective, Multicenter Study. Archives of Iranian medicine 26 (11) (2023)
Abdorreza Naser Moghadasi, Fereshteh Ashtari, Seyed Mohammad Baghbanian, Vahid Shaygannejad, Nassim Anjidani, Fereshteh Ghadiri, Behnaz Sedighi, Morteza Saeidi, Hamed Amirifard, Hormoz Ayromlou, Nahid Beladi Moghadam, Mohammad Bagher Ranjbar, Masoume Nazeri, Zahra Niknam, Fardin Faraji, Afsaneh Afsorde, Mohammad Ali Sahraian
Safety and Effectiveness of Cinnomer ® on Disease Characteristics, Depression, and Quality of Life of Patients with Multiple Sclerosis: A Phase IV, Post-marketing, Prospective, Multicenter Study. Archives of Iranian medicine 26 (11) (2023)
Abdorreza Naser Moghadasi, Fereshteh Ashtari, Seyed Mohammad Baghbanian, Vahid Shaygannejad, Nassim Anjidani, Fereshteh Ghadiri, Behnaz Sedighi, Morteza Saeidi, Hamed Amirifard, Hormoz Ayromlou, Nahid Beladi Moghadam, Mohammad Bagher Ranjbar, Masoume Nazeri, Zahra Niknam, Fardin Faraji, Afsaneh Afsorde, Mohammad Ali Sahraian
Safety and Effectiveness of Cinnomer ® on Disease Characteristics, Depression, and Quality of Life of Patients with Multiple Sclerosis: A Phase IV, Post-marketing, Prospective, Multicenter Study. Archives of Iranian medicine 26 (11) (2023)
Leila Simani, Mahrooz Roozbeh, Maziyar Shojaei, Mohammad Rostami, Mehrdad Roozbeh, Mohammad Ali Sahraian
Cognitive deficits in multiple sclerosis: Auditory and visual attention and inhibitory control. Applied neuropsychology. Adult (2023)
Abdorreza Naser Moghadasi, Fereshteh Ashtari, Seyed Mohammad Baghbanian, Vahid Shaygannejad, Nassim Anjidani, Fereshteh Ghadiri, Behnaz Sedighi, Morteza Saeidi, Hamed Amirifard, Hormoz Ayromlou, Nahid Beladi Moghadam, Mohammad Bagher Ranjbar, Masoume Nazeri, Zahra Niknam, Fardin Faraji, Afsaneh Afsorde, Mohammad Ali Sahraian
Safety and Effectiveness of Cinnomer ® on Disease Characteristics, Depression, and Quality of Life of Patients with Multiple Sclerosis: A Phase IV, Post-marketing, Prospective, Multicenter Study. Archives of Iranian medicine 26 (11) (2023)
Abdorreza Naser Moghadasi, Fereshteh Ashtari, Seyed Mohammad Baghbanian, Vahid Shaygannejad, Nassim Anjidani, Fereshteh Ghadiri, Behnaz Sedighi, Morteza Saeidi, Hamed Amirifard, Hormoz Ayromlou, Nahid Beladi Moghadam, Mohammad Bagher Ranjbar, Masoume Nazeri, Zahra Niknam, Fardin Faraji, Afsaneh Afsorde, Mohammad Ali Sahraian
Safety and Effectiveness of Cinnomer ® on Disease Characteristics, Depression, and Quality of Life of Patients with Multiple Sclerosis: A Phase IV, Post-marketing, Prospective, Multicenter Study. Archives of Iranian medicine 26 (11) (2023)
Amir Valizadeh, Mohammad Reza Fattahi, Maryam Sadeghi, Mehrnush Saghab Torbati, Mohammad Ali Sahraian, Amir Reza Azimi
Disease-modifying therapies and T1 hypointense lesions in patients with multiple sclerosis: A systematic review and meta-analysis. CNS neuroscience & therapeutics 28 (5) (2022)
Fereshteh Ghadiri, Abdorreza Naser Moghadasi, Mohammad Ali Sahraian
Telemedicine as a strategic intervention for cognitive rehabilitation in MS patients during COVID-19. Acta neurologica Belgica 122 (1) (2022)
Mahboobeh Yazdanpanah, Nazanin Jalilian, Rasoul Abdollah Zadeh, Mohammad Ali Sahraian, Mohammad Reza Noori-Daloii
Investigating the association of polymorphisms of ANKRD55 and MMEL1 with susceptibility to multiple sclerosis in Iranian population. The International journal of neuroscience (2021)
Mostafa Almasi-Dooghaee, Mohammad Ali Sahraian, Fahimeh Haji Akhoundi, Hamid Reza Ezzati, Mohammad Rohani
The Factors Associated With Olfactory Dysfunction in Patients with Multiple Sclerosis. Basic and clinical neuroscience 12 (1) (2021)
Raoof Negaresh, Reza Gharakhanlou, Mohammad Ali Sahraian, Maryam Abolhasani, Robert W Motl, Philipp Zimmer
Physical activity may contribute to brain health in multiple sclerosis: An MR volumetric and spectroscopy study. Journal of neuroimaging : official journal of the American Society of Neuroimaging 31 (4) (2021)
Masoud Mohammad Malekzadeh, Reza Alizadeh, Ziba Aghsaeifard, Mohammad Ali Sahraian
Thrombotic Microangiopathy in Interferon-beta-Treated Multiple Sclerosis Patient. Clinical case reports 8 (6) (2020)
Nasim Rezaeimanesh, Mohammad Ali Sahraian, Abdorreza Naser Moghadasi
Evaluation of the Opinion of Patients With Multiple Sclerosis on the Outcomes of Catching COVID-19 and Its Effects on the MS Symptoms. Basic and clinical neuroscience 11 (2) (2020)
Mohaddeseh Azadvari, Abdorreza Naser Moghadasi, Amir Reza Azimi, Farzaneh Sharifiaghdas, Seyede Zahra Emami Razavi, Sharareh Eskandarieh, Maryam Hosseini, Shahram Rahimi-Dehgolan, Mohammad Ali Sahraian
Persian Adaptation of Actionable Bladder Symptom Screening Tool Among Patients with Multiple Sclerosis. Journal of multidisciplinary healthcare 13 (2020)
Nasim Rezaeimanesh, Soodeh Razeghi Jahromi, Zeinab Ghorbani, Abdorreza Naser Moghadasi, Azita Hekmatdoost, Nahid Beladi Moghadam, Mohammad Ali Sahraian
Low carbohydrate diet score and odds of neuromyelitis optica spectrum disorder: A case-control study. International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition (2020)
Mahsa Ghajarzadeh, Abbas Ali Keshtkar, Amir Reza Azimi, Mohammad Ali Sahraian, Mehdi Mohammadifar, Sreeram V Ramagopalan
The Effect of Vitamin D Supplements on Clinical and Para-Clinical Outcomes in Patients With Multiple Sclerosis: Protocol for a Systematic Review. JMIR research protocols 8 (4) (2019)
R Rahmanzadeh, M S Weber, W Brück, S Navardi, Mohammad Ali Sahraian
B cells in multiple sclerosis therapy-A comprehensive review. Acta neurologica Scandinavica 137 (6) (2018)
Saeed Taheri, Mohammad Ali Sahraian, Nazila Yousefi
Cost-effectiveness of alemtuzumab and natalizumab for relapsing-remitting multiple sclerosis treatment in Iran: decision analysis based on an indirect comparison. Journal of medical economics 22 (1) (2018)
Sogol Koolaji, Narges Sistany Allahabadi, Arash Ahmadi, Sharareh Eskandarieh, Abdorreza Naser Moghadasi, Amir Reza Azimi, Mohammad Ali Sahraian
Anti-JC virus antibody sera positivity and index value among patients with multiple sclerosis may be correlated with age, sex, and area of residence. Journal of neurovirology 24 (5) (2018)